Safety and Effectiveness of Nabiximols Oromucosal Spray as Add-on Therapy in Participants With Spasticity Due to Multiple Sclerosis
Clinical trial NCT04203498 · TERMINATED
Trial details
- NCT number
- NCT04203498
- Sponsor
- Jazz Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-01
- Primary completion
- 2023-02-10
- Enrollment
- 139
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.